fda-catalyst-vaccines
Vaccine catalyst analysis across the two-gate path: CBER BLA review and the ACIP recommendation gate that turns FDA approval into commercial availability. Lot release, procurement milestones, pediatric bridging, and healthy-population efficacy context — dated, verified, and sized
Install
npx skills add https://github.com/agentii-ai/agentii-investment-intelligence/tree/main/plugins/vertical-plugins/bio-pharm/skills/agentii/fda-catalyst-vaccines
claude plugin marketplace add https://llmmart.ai/marketplace.json && claude plugin install agentii-ai-agentii-investment-intelligence@llmmart
git clone https://github.com/agentii-ai/agentii-investment-intelligence.git
The skills CLI installs just this skill, for any of its supported agents. Claude Code installs the whole agentii-ai/agentii-investment-intelligence collection as a plugin from our marketplace. Git is the plain clone.
Skill manifest
Methodology inspired by publicly taught vaccine commercial frameworks; all text is an original paraphrase.
Defaults
| Parameter | Default Value | Rationale |
|---|---|---|
| forward_window_quarters | 4 | Standard catalyst window; extend to 8 on request |
| include_superseded | false | Active-only events by default; supersede chains on request |
| acip_gate | true | ACIP status always shown next to FDA decisions — approval is not availability |
| procurement_lens | true | Government purchasing and campaign milestones tracked |
| holiday_labeling | true | Holiday-shifted weeks flagged on every calendar row |
Preflight
Run canonical pre-flight per contracts/preflight.md. Propagate X-Agentii-Trace per contracts/x-agentii-trace-header.md. Confirm ticker resolution via search_companies before catalyst queries.
Triggers
- "When is [vaccine]'s ACIP meeting, and what is the vote outlook?"
- "Is [vaccine] FDA-approved but still awaiting an ACIP recommendation?"
- "What does the ACIP vote mean for [ticker]'s commercial launch?"
- "What procurement milestones are pending for [vaccine/ticker]?"
- "When is lot release expected for [vaccine]?"
- "What pediatric or age-cohort bridging studies are pending?"
- "Build a vaccine catalyst calendar for my watchlist."
- "Which vaccine decisions land this quarter?"
- "How do ACIP recommendation categories change uptake?"
- "What happens between FDA approval and commercial availability?"
- "Which vaccine catalysts overlap with [ticker]'s earnings date?"
- "How did similar vaccines trade around their ACIP votes?"
Production Grounding
- Two-gate path: FDA approval (CBER BLA) is necessary but not sufficient — the ACIP row (scheduled → voted → adopted) is the gate data, with CDC Director sign-off and MMWR publication distinct steps from the vote.
- ACIP recommendation categories (routine / catch-up / risk-based / shared-clinical-decision-making) set the uptake ceiling; votes move stocks like PDUFA dates move drug names.
- CBER context: healthy-population efficacy bar (large N, safety-first), lot-release testing, and manufacturing capacity as a catalyst in its own right.
- Procurement milestones: government stockpiles and purchase contracts (doses/serials, procurement value), seasonal campaign timing.
- Pediatric bridging, booster cycles, and age-cohort expansions re-open the catalyst window after launch.
- Holiday-week labeling discipline: campaign-week comps are noisy; label holiday weeks explicitly. Never fabricate votes, dates, or procurement values (per
references/knowledge-frameworks.md).
Data Source Priority
- ACIP gate data:
search_acip_events/get_acip_event(vote counts, status ladder). - FDA/CBER track:
get_upcoming_pdufa/search_fda_approvals(BLA events). - Panel and filing context:
search_adcom_meetings(VRBPAC) +search_documents/search_sec_filingsfor procurement and lot-release disclosures. - Historical grounding:
search_investment_cases(acip_vote/approval events),search_by_analogue.
Methodology
Retrieval Scope
unstructured_document_search
Retrieval Strategy
- Resolve ticker(s) via
search_companies; note vaccine product names. - Pull ACIP events (
search_acip_events) and FDA-track dates (get_upcoming_pdufa); pair them per product. - For each ACIP event, retrieve vote detail (
get_acip_eventby vaccine + meeting date) and panel context. - Layer procurement and lot-release milestones from filings (
search_sec_filings8-Ks,search_documents). - Ground the play:
search_investment_cases/search_by_analoguewith vaccine filters; cite /v/ records.
Temporal Scope
See frontmatter temporal_scope block. Seasonal campaigns may require looking back up to 8 quarters.
Tool Allowlist
See frontmatter allowed_tools.
Protocol
- Ticker resolution
- Two-gate enumeration (FDA date + ACIP row per product)
- Per-event vote framing (recommendation category + history)
- Procurement and lot-release overlay
- Calendar synthesis + commercial-availability flags
Modes
- Watchlist (default, multi-ticker): one dated calendar with per-ticker sections, sorted by date.
- Single ticker deep-dive: full two-gate timeline per vaccine + procurement state.
- ACIP gate: approval-to-recommendation transition tracking across names.
Tool Fallbacks
| Failure | Fallback |
|---|---|
| search_acip_events empty | search_documents keyword ACIP + search_sec_filings; annotate coverage_gap |
| No ACIP row for a product | Flag the unmodeled commercial step explicitly; never assume approval = launch |
| Procurement data missing | State purchase-contract data unavailable; do not estimate values |
| Knowledge tools empty | Proceed with structured data only; annotate knowledge coverage_gap |
Output File
{ticker}/{YYYY-MM-DD_HHMM}_fda-catalyst-vaccines_{affix}.md (watchlist: watchlist/{YYYY-MM-DD_HHMM}_fda-catalyst-vaccines-calendar_{affix}.md)
Output Structure
- Executive Summary — highest-impact vaccine catalysts in the window, 2-3 sentences
- Two-Gate Calendar — dated table: date, ticker, product, FDA event, ACIP row, holiday-week flag, availability framing
- Per-Event Analysis — vote context (recommendation category, committee read) + decision history
- Procurement & Lot Release — contracts, stockpile status, campaign timing
- Historical Analogues — matched vaccine cases with /v/ citations and quantified outcomes
- Risk Assessment & Coverage Gaps — binary-risk sizing, two-gate failure modes, missing data
Error Handling
| Error | Fallback |
|---|---|
| No ACIP or PDUFA rows | Fall back to earnings + pipeline events; annotate coverage_gap — never fabricate dates |
| Approval without ACIP row | Present the gap as the central risk; do not imply commercial availability |
| Ticker not in med universe | Resolve via CIK/vaccine-universe match; surface the classification gap |
Memory Load
See contracts/memory-load.md.
Snapshot
See contracts/snapshot-synthesis.md.
Final Summary (TUI)
Include ### Key Citations block with 0-10 clickable /v/ URLs.
References
contracts/citation-and-memory.mdcontracts/output-frontmatter-schema.mdcontracts/memory-load.mdcontracts/snapshot-synthesis.mdcontracts/preflight.mdreferences/knowledge-frameworks.md
Files (agentii-investment-intelligence)
-
references
-
knowledge-frameworks.md 4.5 KB
# FDA Catalyst Vaccines — Knowledge Frameworks Static grounding for `fda-catalyst-vaccines` (spec 055). Runtime records are retrieved via the knowledge tools and cited with /v/ URLs; this file carries the two-gate pathway ladder, failure modes, and the pattern disciplines. Shared regulatory scaffolding (scrutiny axes, binary-event sizing) lives in `../../fda-catalyst-analysis/references/knowledge-frameworks.md`. ## The Two-Gate Pathway Ladder 1. **CBER BLA filing**: vaccines are biologics — review sits at CBER, with VRBPAC as the advisory committee. 2. **FDA approval**: necessary but not sufficient. The approval catalyzes the stock, not the market. 3. **ACIP review**: the Advisory Committee on Immunization Practices convenes on product, population, and schedule questions; the status ladder runs scheduled → voted → adopted. 4. **CDC Director sign-off + MMWR publication**: distinct steps from the vote — a voted recommendation becomes policy only after adoption and publication. 5. **Lot release**: each manufactured lot is released by CBER before shipment — a recurring operational gate that can delay a launch. 6. **Procurement + campaign**: government stockpiles and purchase contracts (doses/serials, procurement value), seasonal campaign timing. 7. **Cohort uptake**: ACIP-cohort uptake against the recommendation category sets the commercial trajectory. ## ACIP Recommendation Categories (the uptake ceiling) - **Routine**: full age-based recommendation — the widest commercial gate. - **Catch-up**: populations that missed the routine window. - **Risk-based**: restricted to at-risk groups — a materially smaller market. - **Shared-clinical-decision-making**: provider-patient discretion — the narrowest ceiling. The category, not the vote count, is the commercial data point. ## Failure Modes - **Treating FDA approval as commercial availability**: the ACIP row is the gate data; skipping it inflates the near-term revenue path. - **Conflating the vote with adoption**: CDC Director sign-off and MMWR publication are separate, delayable steps. - **Ignoring procurement timing**: government purchasing is lumpy; a stockpile order is a one-time catalyst, not a run-rate signal. - **Underweighting the healthy-population bar**: safety signals in large healthy cohorts get outsized regulatory scrutiny; the efficacy bar is prevention, not treatment. - **Missing pediatric bridging**: pediatric and age-cohort recommendations re-open the catalyst window after launch. - **Unlabeled holiday weeks**: campaign-week comps across holidays are noise without labels. ## Methodology Patterns (original paraphrase of publicly taught practice) ### Vaccine vocabulary (P1, cross-cutting) Doses/serials, procurement value, ACIP-cohort uptake. Launch tracking: consensus sales ÷ dose price ÷ campaign window → required doses → linear path vs actuals, overlaid with at least two named same-category uptake curves. ### Event-takeaway anatomy (P4) Headline verdict → per-stock takeaways → KOL distillation → vote data and category reads → modeled deltas vs consensus → what's-changed vectors → risk bullets. Conflicting committee reads surfaced verbatim and rated by materiality. ### POS / scenario discipline (cross-cutting) Unadjusted peak x POS = modeled number; the ACIP gate is a POS input, not an afterthought. Bull/base/bear with named-driver grids (category outcome, procurement size, campaign timing); explicit abstention where unquantifiable. ## Structured Data Surfaces - `search_acip_events` / `get_acip_event` — the CDC ACIP calendar with the status ladder and vote counts per vaccine + meeting date. - `get_upcoming_pdufa` / `search_fda_approvals` — CBER BLA dates and history. - `search_adcom_meetings` — VRBPAC meeting records and briefing inventories. ## Cross-Cutting Habits - **Buy-side lens**: track where investor attention sits; the client-question pattern — answer the most common question directly (e.g. "which recommendation category will the ACIP vote land?"); per-name bull/bear pivot conditions tied to the category outcome. - **Living-thesis loop**: estimates move first, ratings last; append exhibits to the prior note, never rewrite; campaign-week labels persist. - **Badge mapping (FR-092)**: verifiable facts `[FACT]`, derived arithmetic `[DEDUCTED]`, judgments `[VIEW]` — with a Category/Count/% summary table. ## Authoring-time citations Spec 055 med strategies and cases are linked here as they reach `approved` status; at runtime retrieve via `search_investment_cases` / `search_by_analogue` and cite with /v/ URLs. -
modes.md 461 B
# fda-catalyst-vaccines — Analyst Mode Definitions Derived from the skill's ## Modes section (spec 046 M1). ### Mode: watchlist **Objective**: One dated vaccine catalyst calendar with per-ticker sections, sorted by date. ### Mode: single-target **Objective**: Full two-gate timeline for one vaccine with procurement and lot-release state. ### Mode: acip-gate **Objective**: Track the approval-to-recommendation transition across names in the universe.
-
-
SKILL.md 7.2 KB
--- name: fda-catalyst-vaccines description: "Vaccine catalyst analysis across the two-gate path: CBER BLA review and the ACIP recommendation gate that turns FDA approval into commercial availability. Lot release, procurement milestones, pediatric bridging, and healthy-population efficacy context — dated, verified, and sized per event." sectors: [med.medicines_biotech, med.medical_devices] multi_ticker_semantics: basket_v1_1 temporal_scope: default_quarters: 4 max_quarters: 8 description: "Forward catalyst window default 4 quarters; up to 8 for multi-season campaign and bridging cycles." allowed_tools: - search_acip_events - get_acip_event - get_upcoming_pdufa - search_adcom_meetings - search_fda_approvals - search_companies - search_documents - search_sec_filings - search_investment_cases - search_by_analogue - search_knowledge_entries retrieval_scope: unstructured_document_search min_tool_diversity: 3 parameter_free: false --- > Methodology inspired by publicly taught vaccine commercial frameworks; all text is an original paraphrase. ## Defaults | Parameter | Default Value | Rationale | |-----------|---------------|-----------| | forward_window_quarters | 4 | Standard catalyst window; extend to 8 on request | | include_superseded | false | Active-only events by default; supersede chains on request | | acip_gate | true | ACIP status always shown next to FDA decisions — approval is not availability | | procurement_lens | true | Government purchasing and campaign milestones tracked | | holiday_labeling | true | Holiday-shifted weeks flagged on every calendar row | ## Preflight Run canonical pre-flight per `contracts/preflight.md`. Propagate X-Agentii-Trace per `contracts/x-agentii-trace-header.md`. Confirm ticker resolution via `search_companies` before catalyst queries. ## Triggers - "When is [vaccine]'s ACIP meeting, and what is the vote outlook?" - "Is [vaccine] FDA-approved but still awaiting an ACIP recommendation?" - "What does the ACIP vote mean for [ticker]'s commercial launch?" - "What procurement milestones are pending for [vaccine/ticker]?" - "When is lot release expected for [vaccine]?" - "What pediatric or age-cohort bridging studies are pending?" - "Build a vaccine catalyst calendar for my watchlist." - "Which vaccine decisions land this quarter?" - "How do ACIP recommendation categories change uptake?" - "What happens between FDA approval and commercial availability?" - "Which vaccine catalysts overlap with [ticker]'s earnings date?" - "How did similar vaccines trade around their ACIP votes?" ## Production Grounding - Two-gate path: FDA approval (CBER BLA) is necessary but not sufficient — the ACIP row (scheduled → voted → adopted) is the gate data, with CDC Director sign-off and MMWR publication distinct steps from the vote. - ACIP recommendation categories (routine / catch-up / risk-based / shared-clinical-decision-making) set the uptake ceiling; votes move stocks like PDUFA dates move drug names. - CBER context: healthy-population efficacy bar (large N, safety-first), lot-release testing, and manufacturing capacity as a catalyst in its own right. - Procurement milestones: government stockpiles and purchase contracts (doses/serials, procurement value), seasonal campaign timing. - Pediatric bridging, booster cycles, and age-cohort expansions re-open the catalyst window after launch. - Holiday-week labeling discipline: campaign-week comps are noisy; label holiday weeks explicitly. Never fabricate votes, dates, or procurement values (per `references/knowledge-frameworks.md`). ## Data Source Priority 1. ACIP gate data: `search_acip_events` / `get_acip_event` (vote counts, status ladder). 2. FDA/CBER track: `get_upcoming_pdufa` / `search_fda_approvals` (BLA events). 3. Panel and filing context: `search_adcom_meetings` (VRBPAC) + `search_documents` / `search_sec_filings` for procurement and lot-release disclosures. 4. Historical grounding: `search_investment_cases` (acip_vote/approval events), `search_by_analogue`. ## Methodology ### Retrieval Scope unstructured_document_search ### Retrieval Strategy 1. Resolve ticker(s) via `search_companies`; note vaccine product names. 2. Pull ACIP events (`search_acip_events`) and FDA-track dates (`get_upcoming_pdufa`); pair them per product. 3. For each ACIP event, retrieve vote detail (`get_acip_event` by vaccine + meeting date) and panel context. 4. Layer procurement and lot-release milestones from filings (`search_sec_filings` 8-Ks, `search_documents`). 5. Ground the play: `search_investment_cases` / `search_by_analogue` with vaccine filters; cite /v/ records. ### Temporal Scope See frontmatter temporal_scope block. Seasonal campaigns may require looking back up to 8 quarters. ### Tool Allowlist See frontmatter allowed_tools. ### Protocol 1. Ticker resolution 2. Two-gate enumeration (FDA date + ACIP row per product) 3. Per-event vote framing (recommendation category + history) 4. Procurement and lot-release overlay 5. Calendar synthesis + commercial-availability flags ## Modes - **Watchlist** (default, multi-ticker): one dated calendar with per-ticker sections, sorted by date. - **Single ticker deep-dive**: full two-gate timeline per vaccine + procurement state. - **ACIP gate**: approval-to-recommendation transition tracking across names. ## Tool Fallbacks | Failure | Fallback | |---------|----------| | search_acip_events empty | `search_documents` keyword ACIP + `search_sec_filings`; annotate coverage_gap | | No ACIP row for a product | Flag the unmodeled commercial step explicitly; never assume approval = launch | | Procurement data missing | State purchase-contract data unavailable; do not estimate values | | Knowledge tools empty | Proceed with structured data only; annotate knowledge coverage_gap | ## Output File `{ticker}/{YYYY-MM-DD_HHMM}_fda-catalyst-vaccines_{affix}.md` (watchlist: `watchlist/{YYYY-MM-DD_HHMM}_fda-catalyst-vaccines-calendar_{affix}.md`) ## Output Structure 1. **Executive Summary** — highest-impact vaccine catalysts in the window, 2-3 sentences 2. **Two-Gate Calendar** — dated table: date, ticker, product, FDA event, ACIP row, holiday-week flag, availability framing 3. **Per-Event Analysis** — vote context (recommendation category, committee read) + decision history 4. **Procurement & Lot Release** — contracts, stockpile status, campaign timing 5. **Historical Analogues** — matched vaccine cases with /v/ citations and quantified outcomes 6. **Risk Assessment & Coverage Gaps** — binary-risk sizing, two-gate failure modes, missing data ## Error Handling | Error | Fallback | |-------|----------| | No ACIP or PDUFA rows | Fall back to earnings + pipeline events; annotate `coverage_gap` — never fabricate dates | | Approval without ACIP row | Present the gap as the central risk; do not imply commercial availability | | Ticker not in med universe | Resolve via CIK/vaccine-universe match; surface the classification gap | ## Memory Load See `contracts/memory-load.md`. ## Snapshot See `contracts/snapshot-synthesis.md`. ## Final Summary (TUI) Include ### Key Citations block with 0-10 clickable /v/ URLs. ## References - `contracts/citation-and-memory.md` - `contracts/output-frontmatter-schema.md` - `contracts/memory-load.md` - `contracts/snapshot-synthesis.md` - `contracts/preflight.md` - `references/knowledge-frameworks.md`
Comments (0)
Sign in to join the conversation.
Reviews (0)
No reviews yet.
No comments yet.